Summary:
Click image to enlarge
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects with Moderate to Severe Chronic Plaque Psoriasis
Qualified Participants Must:
• Be 18 years of age or older
•
Have chronic plaque-type psoriasis diagnosed for at least 6 months
•
Be willing and able to comply with scheduled visits, study assessments and laboratory tests, and other study procedures
Qualified Participants May Receive:
Study-related care
Study-related medication
Compensation for time and travel